Dimensional Fund Advisors

Dimensional Fund Advisors Portfolio holdings

AUM $466B
1-Year Est. Return 20.66%
 

Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.

This Quarter Est. Return
1 Year Est. Return
+20.66%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$466B
AUM Growth
+$34.1B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
3,356
New
Increased
Reduced
Closed

Top Buys

1 +$520M
2 +$440M
3 +$293M
4
AVGO icon
Broadcom
AVGO
+$268M
5
MSFT icon
Microsoft
MSFT
+$256M

Top Sells

1 +$453M
2 +$237M
3 +$217M
4
SKX
Skechers
SKX
+$201M
5
COF icon
Capital One
COF
+$187M

Sector Composition

1 Technology 21.99%
2 Financials 17.98%
3 Industrials 11.99%
4 Consumer Discretionary 10.49%
5 Healthcare 9.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GEVO icon
3101
Gevo
GEVO
$506M
$240K ﹤0.01%
122,322
-131,767
CNVS icon
3102
Cineverse
CNVS
$39.3M
$238K ﹤0.01%
70,781
+20,616
OPXS icon
3103
Optex Systems
OPXS
$88.1M
$237K ﹤0.01%
18,394
+2,438
AXIA.PR
3104
AXIA Energia Preferred Shares
AXIA.PR
$27.6B
$233K ﹤0.01%
22,431
RAPT icon
3105
RAPT Therapeutics
RAPT
$919M
$231K ﹤0.01%
+8,934
PLRX icon
3106
Pliant Therapeutics
PLRX
$75M
$225K ﹤0.01%
151,673
-164,214
FBLA
3107
FB Bancorp
FBLA
$243M
$224K ﹤0.01%
+18,596
LB
3108
LandBridge Co
LB
$1.48B
$223K ﹤0.01%
+4,182
HBIO icon
3109
Harvard Bioscience
HBIO
$35.1M
$218K ﹤0.01%
496,144
-630,106
RMNI icon
3110
Rimini Street
RMNI
$370M
$214K ﹤0.01%
45,571
+18,472
CSAN icon
3111
Cosan
CSAN
$4.15B
$212K ﹤0.01%
46,100
+644
STKS icon
3112
The ONE Group
STKS
$58.2M
$210K ﹤0.01%
70,839
+18,435
TARA icon
3113
Protara Therapeutics
TARA
$276M
$208K ﹤0.01%
47,708
-37,595
NHTC icon
3114
Natural Health Trends
NHTC
$37.2M
$206K ﹤0.01%
46,061
+731
MYPS icon
3115
PLAYSTUDIOS Inc
MYPS
$84.2M
$205K ﹤0.01%
213,073
-1,895
SNDA icon
3116
Sonida Senior Living
SNDA
$585M
$204K ﹤0.01%
7,368
-11,927
SKLZ icon
3117
Skillz
SKLZ
$75.8M
$203K ﹤0.01%
25,369
-3,454
PPTA
3118
Perpetua Resources
PPTA
$3.14B
$202K ﹤0.01%
9,986
-15,053
GFR icon
3119
Greenfire Resources
GFR
$357M
$200K ﹤0.01%
43,163
HFBL icon
3120
Home Federal Bancorp
HFBL
$54M
$198K ﹤0.01%
14,511
GAU
3121
Galiano Gold
GAU
$636M
$197K ﹤0.01%
+89,916
IZEA icon
3122
IZEA Worldwide
IZEA
$80.5M
$197K ﹤0.01%
52,932
-850
AWX icon
3123
Avalon Holdings
AWX
$10.3M
$195K ﹤0.01%
74,597
DNA icon
3124
Ginkgo Bioworks
DNA
$499M
$194K ﹤0.01%
13,316
+519
NMRA icon
3125
Neumora Therapeutics
NMRA
$301M
$191K ﹤0.01%
104,983